Skip Navigation
Skip to contents

ICDM 2018

Main symposia

S1 Diabetes, retina, vision :
Diabetic retinopathy: out of sight, out of mind
16:00~17:30 / Thursday 11 October
Convention hall C
Chairman: TBD
Overview

Organizers: Nan Hee Kim, Jaetaek Kim

This session entitled with 'Diabetes, retina, vision' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel mechanisms and potential therapeutic areas for diabetic retinopathy. Clinical ophthalmology and basic research have complimentarily accumulated invaluable information of drug discovery for diabetic retinopathy. In this session, invited speakers will present the utility of experimental mouse retinal models, and the perspectives on new drugs targeting vascular signals.
Dong Ho Park
Kyungpook National University, Korea
Dong Ho Park
S1-1 A new approach to retinal vascular diseases
Jun Yeop Lee
Yeungnam University , Korea
TBD
S1-2 Novel target for diabetic chorioretinopathy
Akiyoshi Uemura
Nagoya City University, Japan
Akiyoshi Uemura
S1-3 Sustained inflammation and fibrosis in pericyte-deficient retina
Panel Discussion
Nan Hee Kim (Korea University, Korea)
Jaetaek Kim (Chung-Ang University, Korea)
S4 Diabetes, cognition :
Beyond old paradigm : diabetes-associated cognitive dysfunction
09:00~10:40 / Friday 12 October
Convention hall C
Chairman: TBD
Overview

Organizers: Nan Hee Kim, Jaetaek Kim

This session entitled with 'Diabetes, cognition' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel mechanisms and potential therapeutic areas for diabetic cognitive dysfunction. Although microvascular and macrovascular complications of diabetes are well recognized, there is a lack of awareness regarding other complications such as cognitive dysfunction, and dementia. In this session, invited speakers will explain the interconnecting link between diabetes and cognitive dysfunction. This session will be the important step toward better understanding the cognitive dysfunction in diabetes.
Seung Hwan Lee
The Catholic University of Korea, Korea
Seung Hwan Lee
S4-1 Connections between diabetes and cognitive dysfunction: cause or consequence?
Martin Holzenberger
INSERM and Sorbonne University, France
Martin Holzenberger
S4-2 Neuroprotective effect of inulin signaling defect
Sun Ah Park
KAIST, Korea
TBD
S4-3 Neuroprotective effect of insulin signaling
Panel Discussion
Nan Hee Kim (Korea University, Korea)
Jaetaek Kim (Chung-Ang University, Korea)
S9 Diabetes, epigenetics, complications :
Epigenetics: cutting-edge research - application to diabetic complications
13:20~15:20 / Friday 12 October
Convention hall C
Chairman: TBD
Overview

Organizers: Nan Hee Kim, Jae Taek Kim

This session entitled with 'Diabetes, epigenetics, complications' is translational session and designed to provide a place for clinicians and basic researchers to understand epigenetics of diabetic complications. Epigenetic modifications are one of the most important means for the temporal and spatial control of gene activity. Many studies indicate that specific epigenetic events contribute to programming for the development and progression of diabetic complications. The invited speakers will present their recent works successfully using these strategies to identify novel mechanisms influencing diabetic complications.
E. Dale Abel
University of Iowa, USA
Dale Abel
S9-1 Lipid and ROS-induced mechanisms for diabetic cardiomyopathy
Young-Kook Kim
Chonnam National University, Korea
S9-2
S9-2 Study of noncoding RNAs in vascular smooth muscle cells
Kyung Gon Kim
University of Ulsan, Korea
S9-3
S9-3 Urinary Proteomics in diabetic nephropathy
Panel Discussion
Sang Soo Kim (Pusan National University, Korea)
Kyu-Sang Park (Yonsei University, Korea)
Chan Bae Park (Ajou University, Korea)
S15 Diabetes, microvascular, complications :
Three questions we felt very difficult in practice
09:00~11:00 / Saturday 13 October
Convention hall C
Chairman: TBD
Overview

Organizers: Nan Hee Kim, Jae Taek Kim

This session entitled with 'Diabetes, microvascular, complications' is translational session and designed to provide a place for clinicians and basic researchers to understand the important pathophysiologic mechanisms of diabetic microvascular complications. Although there has been a big improvement in the treatment and prognosis of diabetic kidney disease (DKD), there remains an unmet need for innovative treatment. The invited speakers will present the overview of recent preclinical and clinical studies of DKD and the connections between diabetic vascular complications, which demonstrate new insights to outline directions with respect to novel therapies.
Sang Heon Song
Pusan National University, Korea
TBD
S15-1 Acute kidney injury: mechanism of AKI sensitivity in diabetic nephropathy
Mark E Cooper
Monash University, Australia
Mark Cooper
S15-2 Long journey to overcome diabetic kidney disease. where are we?
Jeong Hun Kim
Seoul National University, Korea
Jeong Hun Kim
S15-3 Therapeutic application of in vivo genome editing for diabetic retinopathy
S18 Diabetic neuropathy :
What do we know and we do not know about diabetic neuropathy in diabetes
14:30~16:30 / Saturday 13 October
Convention hall C
Chairman: TBD
Overview

Organizer: Chong Hwa Kim

This session entitled with 'Diabetic neuropathy' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel pathophysiologies and potential therapeutic areas for diabetic neuropathy in patient with diabetes. In this session, overview of cardiovascular autonomic neuropathy, pathogenesis of diabetic neuropathy from Schwann cell and in diabetes and a new hope of therapeutic agents in diabetic peripheral neuropathy, will be presented and discussed. This session will be provide the better understanding of pathophysiology and managemt of diabetic neuropathy included diabetic peripheral neuropathy and cardiac autonomic neuropathy.
Vincenza Spallone
University of Tor Vergata, Italy
S18-1
S18-1 Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
Koichi kato
Aichi Gakuin University, Japan
TBD
S18-2 Pathogenesis of diabetic neuropathy from the point of view of Schwann cell abnormalities
Tae Sun Park
Chonbuk National University, Korea
S18-3
S18-3 New hope in management of DPN
Panel Discussion
Eun Young Lee (The Catholic University of Korea, Korea)
Jae Seung Yun (The Catholic University of Korea, Korea)
Chong Hwa Kim (Sejong general hospital, Korea)